Navigating the Nexus of Addiction, HCV Infection, and HIV Infection

Download All
In this comprehensive online program customized for busy specialists, expert faculty review clinical strategies for preventing and identifying HCV/HIV infection in PWID, along with comanaging addiction in the setting of viral infection.
Jenna Butner, MD
Chinazo Cunningham, MD, MS
Tiffany Lu, MD, MS

ClinicalThought

Although it can be challenging, HIV risk counseling is an important component of substance use disorder care. As addiction care providers are considering barriers to these discussions, we need to ask ourselves, if not now, when? Here’s my take on addressing this critical issue.

Jenna Butner, MD Released: August 24, 2020

In parallel with the opioid epidemic, HCV and HIV outbreaks have ravaged through communities with high rates of opioid overdose, placing HCV and HIV clinicians on the frontlines of these colliding epidemics. So, how do we begin to integrate life-saving treatment for OUD into our practices?

Chinazo Cunningham, MD, MS Tiffany Lu, MD, MS Released: October 22, 2020
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
American Society of Addiction Medicine
Educational grant provided by:
Gilead Sciences

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue